The protective effects of metyrosine, lacidipine, clonidine, and moxonidine on kidney damage induced by unilateral ureteral obstruction in rats

Surgery Today

Volumn 42, Issue 11, 2012, Pages 1051-1060

  Yigiter, Murat ^a   Yildiz, Abdullah ^b   Polat, Beyzagul ^a   Alp, Hamit Hakan ^a   Keles, Osman Nuri ^a   Salman, Ahmet Bedii ^a   Suleyman, Halis ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b Department of Pediatric Surgery   (Turkey)

Author keywords

Clonidine; Lacidipine; Metyrosine; Moxonidine; Rat; Ureter ligation

Indexed keywords

8 HYDROXY 2 DEOXYGUANINE; CLONIDINE; COLLAGEN; DNA; GLUTATHIONE; GUANINE DERIVATIVE; LACIDIPINE; MALONALDEHYDE; METIROSINE; MOXONIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GLOMERULOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; KIDNEY INJURY; KIDNEY PARENCHYMA; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE DISORDER; MALE; MICROSCOPY; NEPHRITIS; NONHUMAN; OUTCOME ASSESSMENT; RAT; RENAL PROTECTION; SPECTROPHOTOMETRY; TREATMENT DURATION; URETER LIGATION; URETER OBSTRUCTION;

ACUTE KIDNEY INJURY; ALPHA-METHYLTYROSINE; ANIMALS; BIOPSY, NEEDLE; CLONIDINE; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; URETERAL OBSTRUCTION;

EID: 84867996350     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-011-0074-8     Document Type: Article

References (45)

1. Moosavi SM, Ashtiyani SC, Hosseinkhani S, Shirazi M. Comparison of the effects of L-carnitine and alpha-tocopherol on acute ureteral obstruction-induced renal oxidative imbalance and altered energy metabolism in rats. Urol Res. 2010;38:187-94.
2. Chevalier RL, Peters CA. Congenital urinary tract obstruction: proceedings of the state-of-the-art strategic planning workshop, National Institutes of Health, Bethesda, Maryland, USA, 11-12 March 2002. Pediatr Nephrol. 2003;18:576-606. (Pubitemid 36790102)
3. Felsen D, Loo MH, Vaughan ED Jr. Effect of ureteral obstruction on renal hemodynamics. Semin Urol. 1987;5:160-6.
4. Fink RL, Caridis DT, Chmiel R, Ryan G. Renal impairment and its reversibility following variable periods of complete ureteric obstruction. Aust N Z J Surg. 1980;50:77-83. (Pubitemid 10141939)
5. Anderson D. Antioxidant defences against reactive oxygen species causing genetic and other damage. Mutat Res. 1996;350: 103-8. (Pubitemid 26072403)
6. Naito Y, Yoshikawa T, Yoshida N, Kondo M. Role of oxygen radical and lipid peroxidation in indomethacin-induced gastric mucosal injury. Dig Dis Sci. 1998;43:30S-4S. (Pubitemid 28433946)
7. Bast A, Haenen GR, Doelman CJ. Oxidants and antioxidants: state of the art. Am J Med. 1991;91:2S-13S.
8. Grollman AP, Moriya M. Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet. 1993;9:246-9. (Pubitemid 23188487)
9. Polat B, Suleyman H, Alp HH. Adaptation of rat gastric tissue against indomethacin toxicity. Chem Biol Interact. 2010;186: 82-9.
10. Mizuguchi Y, Miyajima A, Kosaka T, Asano T, Hayakawa M. Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. J Urol. 2004;172:2456-9. (Pubitemid 39507552)
11. Moriyama T, Kawada N, Nagatoya K, Takeji M, Horio M, Ando A, et al. Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney Int. 2001;59:2095-103. (Pubitemid 32467601)
12. Albayrak A, Polat B, Cadirci E, Hacimuftuoglu A, Halici Z, Gulapoglu M, et al. Gastric anti-ulcerative and anti-inflammatory activity of metyrosine in rats. Pharmacol Rep. 2010;62:113-9.
13. Halici Z, Borekci B, Ozdemir Y, Cadirci E, Suleyman H. Protective effects of amlodipine and lacidipine on ovariectomyinduced bone loss in rats. Eur J Pharmacol. 2008;579:241-5.
14. Poyhonen-Alho MK, Manhem K, Katzman P, Kibarskis A, Antikainen RL, Erkkola RU, et al. Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women. J Hypertens. 2008;26:2445-9.
15. Robert B, Petit JY, Grimaud N, Juge M, Welin L. Effect of clonidine on experimental brain edema in the rat. Agents Actions. 1992;37:268-72. (Pubitemid 23062756)
16. Suleyman H, Halici Z, Hacimuftuoglu A, Gocer F. Role of adrenal gland hormones in antiinflammatory effect of calcium channel blockers. Pharmacol Rep. 2006;58:692-9. (Pubitemid 44741688)
17. Nasrallah HA, Donnelly EF, Bigelow LB, Rivera-Calimlim L, Rogol A, Potkin S, et al. Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosine. Arch Gen Psychiatry. 1977;34:649-55. (Pubitemid 8131489)
18. De Paoli P, Cerbai E, Koidl B, Kirchengast M, Sartiani L, Mugelli A. Selectivity of different calcium antagonists on T- and L-type calcium currents in guinea-pig ventricular myocytes. Pharmacol Res. 2002;46:491-7. (Pubitemid 35435690)
19. Chachua T, Bilanishvili I, Khizanishvili N, Nanobashvili Z. Noradrenergic modulation of seizure activity. Georgian Med News. 2010:34-9.
20. Nasr MA, El-Gowilly SM, El-Mas MM. Comparable renovascular protective effects of moxonidine and simvastatin in rats exposed to cigarette smoke. Vascul Pharmacol. 2010;53:53-60.
21. Salman S, Kumbasar S, Yilmaz M, Kumtepe Y, Borekci B, Bakan E, et al. Investigation of the effects of the chronic administration of some antihypertensive drugs on enzymatic and nonenzymatic oxidant/antioxidant parameters in rat ovarian tissue. Gynecol Endocrinol. 2011;27:895-9.
22. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin- 1. J Am Soc Nephrol. 2001;12:1434-47. (Pubitemid 32666326)
23. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968;25:192-205.
24. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-8. (Pubitemid 9194347)
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
26. Kaur H, Halliwell B. Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection. Biochem J. 1996;318(Pt 1):21-3. (Pubitemid 26283620)
27. Floyd RA, Watson JJ, Wong PK, Altmiller DH, Rickard RC. Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation. Free Radic Res Commun. 1986;1:163-72.
28. Asami S, Hirano T, Yamaguchi R, Tomioka Y, Itoh H, Kasai H. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res. 1996;56:2546-9. (Pubitemid 26170692)
29. Del Soldato P. Gastric lesion-preventing or -potentiating activity of clonidine in rats. Jpn J Pharmacol. 1986;41:257-9. (Pubitemid 16078713)
30. Suleyman H, Halici Z, Cadirci E, Hacimuftuoglu A, Keles S, Gocer F. Indirect role of alpha2-adrenoreceptors in anti-ulcer effect mechanism of nimesulide in rats. Naunyn Schmiedebergs Arch Pharmacol. 2007;375:189-98. (Pubitemid 46525449)
31. Suleyman H, Dursun H, Bilici M, Cadirci E, Halici Z, Gulaboglu M, et al. Relation of adrenergic receptors, which have roles in gastroprotective and anti-inflammatory effect of adrenal gland hormones, with cyclooxygenase enzyme levels in rats. J Physiol Pharmacol. 2009;60:129-34.
32. Suleyman H, Demircan B, Karagoz Y. Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacol Rep. 2007;59:247-58. (Pubitemid 47299726)
33. Suleyman H, Halici Z, Cadirci E, Hacimuftuoglu A, Bilen H. Indirect role of beta2-adrenergic receptors in the mechanism of anti-inflammatory action of NSAIDS. J Physiol Pharmacol. 2008;59:661-72.
34. Suleyman H, Cadirci E, Albayrak A, Halici Z. Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug. Curr Med Chem. 2008;15:278-83. (Pubitemid 351260493)
35. Ghanayem BI, Boor PJ, Ahmed AE. Acrylonitrile-induced gastric mucosal necrosis: role of gastric glutathione. J Pharmacol Exp Ther. 1985;232:570-7. (Pubitemid 15169878)
36. Stein HJ, Hinder RA, Oosthuizen MM. Gastric mucosal injury caused by hemorrhagic shock and reperfusion: protective role of the antioxidant glutathione. Surgery 1990;108:467-73 (discussion 473-4).
37. Lomaestro BM, Malone M. Glutathione in health and disease: pharmacotherapeutic issues. Ann Pharmacother. 1995;29: 1263-73. (Pubitemid 26044866)
38. Blaustein A, Deneke SM, Stolz RI, Baxter D, Healey N, Fanburg BL. Myocardial glutathione depletion impairs recovery after short periods of ischemia. Circulation. 1989;80:1449-57. (Pubitemid 19282534)
39. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest. 1982;47:412-26. (Pubitemid 13229679)
40. Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res. 1999;424:83-95.
41. Milligan JR, Ward JF. Yield of single-strand breaks due to attack on DNA by scavenger-derived radicals. Radiat Res. 1994;137:295-9. (Pubitemid 24098256)
42. Cadet J, Douki T, Gasparutto D, Ravenna JL. Oxidative damage to DNA: formation, measurement and biochemical features. Mutat Res. 2003;531:5-23. (Pubitemid 37456721)
43. Collins AR, Dusinska M, Gedik CM, Stetina R. Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect. 1996;104(Suppl 3):465-9.
44. Borekci B, Kumtepe Y, Karaca M, Halici Z, Cadirci E, Albayrak F, et al. Role of alpha-2 adrenergic receptors in anti-ulcer effect mechanism of estrogen and luteinising hormone on rats. Gynecol Endocrinol. 2009;25:264-8.
45. Kumtepe Y, Borekci B, Karaca M, Salman S, Alp HH, Suleyman H. Effect of acute and chronic administration of progesterone, estrogen, FSH and LH on oxidant and antioxidant parameters in rat gastric tissue. Chem Biol Interact. 2009;182:1-6.